spacer
home > pmps > spring 2019 > finding the right solution
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Finding the Right Solution

Demand from healthcare providers for treatments that are both clinically effective and commercially sustainable continues to put pressure on the pharmaceutical industry’s bottom line. This, combined with increasingly stringent regulations, means drug companies need to redouble efforts to ensure the economic delivery of treatments, and they need to accomplish this without jeopardising the quality or safety of their products. Optimising the use of packaging is an important step towards achieving these goals.

An Evolving Business Environment

A major challenge facing firms is that pharma manufacturing processes and supply chains now need to accommodate both generic, bulk-produced products and newer small batch options. With production becoming increasingly based on demand and pharma companies reducing inventory for many drug lines, a more agile supply chain is essential to ensure operational efficiency.

Addressing these issues will require closer collaboration with packaging suppliers with a deep understanding of material science and a proven ability to create cost-effective, innovative, and robust designs. Offering tailored designs that provide mandatory levels of security at a price that lowers costs is just one part of the process − they also need to be delivered quickly and economically.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kori Anderson is Honeywell’s General Manager for Healthcare Packaging. At this year’s Pharmapack Expo, Honeywell launched a new pharmaceutical packaging solution, Aclar Accel.
spacer
Kori Anderson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A new anti-tumour treatment is one step closer to the clinic thanks to a new collaboration between In3Bio and 3P Biopharmaceuticals

[Pamplona, November 26 2019] 3P Biopharmaceuticals, a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has been chosen by In3Bio, a UK based Biotech company, to collaborate in the development of a novel anti-tumour treatment.
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement